Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

about

Therapeutic considerations for postprandial dyslipidaemia.Hepatic lipase deficiency.Effects of drugs on postprandial lipoprotein metabolism.Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients.

P2860

Q34285956-F2F63DC4-AB76-4F39-9D57-CC3EF949881D Q34756336-B2C9540C-BDC9-471B-ABC4-987DCB8A4786 Q41571866-D39B8A85-E024-4026-A399-1AAD4466DF18 Q44387520-08F84821-5A20-4407-B836-2573EF0E874C

P2860

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

Item

http://www.wikidata.org/entity/Q51619077

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

1989年學術文章

@zh-hant

name

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@en

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@nl

type

Item

label

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@en

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@nl

prefLabel

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@en

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@nl

P1476

Lovastatin reduces postprandia ...... th mild hypertriglyceridaemia.

@en

P2093

Breslow JL

http://www.w3.org/2001/XMLSchema#string

Eisenberg S

http://www.w3.org/2001/XMLSchema#string

Weintraub MS

http://www.w3.org/2001/XMLSchema#string

P2860

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

RELATIONSHIP BETWEEN PLASMA TRIGLYCERIDES AND REMOVAL OF CHYLOMICRONS

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity.

Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.

Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).

Chylomicron clearance in normal and hyperlipidemic man.

Atherogenesis: a postprandial phenomenon.

P304

480-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2362.1989.TB00263.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1989-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2511025

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

hypercholesterolemia

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

about

P2860

P2860

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921